Microgyrus
Microgyrus
Microgyrus is a rare neurological condition characterized by the presence of small, abnormal folds in the cerebral cortex of the brain. These abnormal folds, known as microgyri, can disrupt normal brain development and function, leading to a variety of neurological symptoms.
Symptoms of Microgyrus can vary depending on the location and severity of the abnormal folds. Common symptoms may include developmental delays, intellectual disability, seizures, motor impairments, and speech and language difficulties. In some cases, individuals with Microgyrus may also experience behavioral issues and psychiatric disorders.
The exact cause of Microgyrus is not well understood, but it is believed to result from disruptions in early brain development during pregnancy. Factors that may contribute to the development of Microgyrus include genetic mutations, prenatal infections, exposure to toxins, and other environmental factors.
Diagnosis of Microgyrus typically involves a combination of medical history, physical examination, neuroimaging studies such as magnetic resonance imaging (MRI), and genetic testing. Treatment options for Microgyrus are limited and focus on managing symptoms and providing supportive care. This may include medications to control seizures, physical therapy to improve motor function, speech therapy to address communication difficulties, and educational interventions to support learning and development.
Research into Microgyrus is ongoing, with a focus on understanding the underlying mechanisms of the condition, developing new diagnostic tools, and exploring potential treatment strategies. Early intervention and multidisciplinary care involving neurologists, geneticists, developmental pediatricians, and other specialists are important for optimizing outcomes for individuals with Microgyrus.
For more information on related neurological conditions, please visit the neurological disorders page.
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian